Antibe is either doing 'B' or has probably bottomed out.
Trend lines and crossovers also support an up move.
Very likely to hit the 1st target. Could hit the second and continue the up move if the +ve divergence stays.
On the daily we have the rsi above the 50 level pointing up up and a macd kiss on the positive side. Looking at the price action we can see the price action above the 8, 21, and 55 ema , but will under the 200 ema, as well as a neckline for a possible inverse head and shoulders breakout. They have just up listed to the TSX with potential to uplist to the NASDAQ. ...
Trade opportunity to the top of a well defined channel, with a possible 13% gain.
Indicators quite bullish as MACD reverses of the zero line, histogram ticking higher and green.
RSI in strong move.
Company profile
Antibe Therapeutics, Inc. is a biotechnology company, which engages in the development of medicines for pain and inflammation. It operates through the...
